The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke: The CATIS Randomized Clinical Trial
Abstract
IMPORTANCE: Although the benefit of reducing blood pressure for primary and secondary prevention of stroke has been established, the effect of antihypertensive treatment in patients with acute ischemic stroke is uncertain. OBJECTIVE: To evaluate whether immediate blood pressure reduction in patients with acute ischemic stroke would reduce death and major disability at 14 days or hospital discharge. DESIGN, SETTING, AND PARTICIPANTS: The China Antihypertensive Trial in Acute Ischemic Stroke, a single-blind, blinded end-points randomized clinical trial, conducted among 4071 patients with nonthrombolysed ischemic stroke within 48 hours of onset and elevated systolic blood pressure. Patients were recruited from 26 hospitals across China between August 2009 and May 2013. INTERVENTIONS: Patients (n = 2038) were randomly assigned to receive antihypertensive treatment (aimed at lowering systolic blood pressure by 10% to 25% within the first 24 hours after randomization, achieving blood pressure less than 140/90 mm Hg within 7 days, and maintaining this level during hospitalization) or to discontinue all antihypertensive medications (control) during hospitalization (n = 2033). MAIN OUTCOMES AND MEASURES: Primary outcome was a combination of death and major disability (modified Rankin Scale score ≥3) at 14 days or hospital discharge. RESULTS: Mean systolic blood pressure was reduced from 166.7 mm Hg to 144.7 mm Hg (-12.7%) within 24 hours in the antihypertensive treatment group and from 165.6 mm Hg to 152.9 mm Hg (-7.2%) in the control group within 24 hours after randomization (difference, -5.5% [95% CI, -4.9 to -6.1%]; absolute difference, -9.1 mm Hg [95% CI, -10.2 to -8.1]; P < .001). Mean systolic blood pressure was 137.3 mm Hg in the antihypertensive treatment group and 146.5 mm Hg in the control group at day 7 after randomization (difference, -9.3 mm Hg [95% CI, -10.1 to -8.4]; P < .001). The primary outcome did not differ between treatment groups (683 events [antihypertensive treatment] vs 681 events [control]; odds ratio, 1.00 [95% CI, 0.88 to 1.14]; P = .98) at 14 days or hospital discharge. The secondary composite outcome of death and major disability at 3-month posttreatment follow-up did not differ between treatment groups (500 events [antihypertensive treatment] vs 502 events [control]; odds ratio, 0.99 [95% CI, 0.86 to 1.15]; P = .93). CONCLUSION AND RELEVANCE: Among patients with acute ischemic stroke, blood pressure reduction with antihypertensive medications, compared with the absence of hypertensive medication, did not reduce the likelihood of death and major disability at 14 days or hospital discharge. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01840072.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Individual Comparisons by Ranking Methods
Wilcoxon, F. (1945) · Biometrics Bulletin · doi:10.2307/3001968 · Cited by 15,354
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Self-citationMeasurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
Anderson, C. S., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214609 · Cited by 1,614
Self-citationRecovery of motor function after stroke.
Bonita, R., & Beaglehole, R. (1988) · Stroke · doi:10.1161/01.str.19.12.1497 · Cited by 1,288
Chen, Z.-M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04010-5 · Cited by 1,232
Saver, J. L., Fonarow, G. C., Smith, E. E., Reeves, M. J., Grau-Sepulveda, M. V., Pan, W., Olson, D. M., Hernandez, A. F., Peterson, E. D., & Schwamm, L. H. (2013) · JAMA · doi:10.1001/jama.2013.6959 · Cited by 870
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
(2013) · The Lancet · doi:10.1016/s0140-6736(13)60852-1 · Cited by 749
The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
Schrader, J., Lüders, S., Kulschewski, A., Berger, J., Zidek, W., Treib, J., Einhäupl, K., Diener, H. C., & Dominiak, P. (2003) · Stroke · doi:10.1161/01.str.0000075777.18006.89 · Cited by 652
Sandset, E. C., Bath, P. M., Boysen, G., Jatuzis, D., Kõrv, J., Lüders, S., Murray, G. D., Richter, P. S., Roine, R. O., Terént, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60104-9 · Cited by 541
Castillo, J., Leira, R., García, M. M., Serena, J., Blanco, M., & Dávalos, A. (2004) · Stroke · doi:10.1161/01.str.0000109769.22917.b0 · Cited by 504
Qureshi, A. I., Ezzeddine, M. A., Nasar, A., Suri, M. F. K., Kirmani, J. F., Hussein, H. M., Divani, A. A., & Reddi, A. S. (2007) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2006.07.008 · Cited by 459
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J. W., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2005.04377.x · Cited by 436
Potter, J. F., Robinson, T. G., Ford, G. A., Mistri, A., James, M., Chernova, J., & Jagger, C. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70263-1 · Cited by 331
Effect of Intravenous Nimodipine on Blood Pressure and Outcome After Acute Stroke
Ahmed, N., Näsman, P., & Wahlgren, N. G. (2000) · Stroke · doi:10.1161/01.str.31.6.1250 · Cited by 324
Statistical Analysis of the Primary Outcome in Acute Stroke Trials
Bath, P. M. W., Lees, K. R., Schellinger, P. D., Altman, H., Bland, M., Hogg, C., Howard, G., & Saver, J. L. (2012) · Stroke · doi:10.1161/strokeaha.111.641456 · Cited by 266
Robinson, T. G., Potter, J. F., Ford, G. A., Bulpitt, C. J., Chernova, J., Jagger, C., James, M. A., Knight, J., Markus, H. S., Mistri, A. K., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70163-0 · Cited by 247
Wang, Y., Liao, X., Zhao, X., Wang, D. Z., Wang, C., Nguyen-Huynh, M. N., Zhou, Y., Liu, L., Wang, X., Liu, G., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.604249 · Cited by 230
Self-citationThompson, A. M. (2011) · JAMA · doi:10.1001/jama.2011.250 · Cited by 215
Analysis and interpretation of data
(2014) · The Hard-pressed Researcher · doi:10.4324/9781315838946-11 · Cited by 193
Kaste, M., Fogelholm, R., Erilä, T., Palomäki, H., Murros, K., Rissanen, A., & Sarna, S. (1994) · Stroke · doi:10.1161/01.str.25.7.1348 · Cited by 181
Blood Pressure and Functional Recovery in Acute Ischemic Stroke
Chamorro, Á., Vila, N., Ascaso, C., Elices, E., Schonewille, W. J., & Blanc, R. (1998) · Stroke · doi:10.1161/01.str.29.9.1850 · Cited by 152
Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China
Zhang, Y., Reilly, K. H., Tong, W., Xu, T., Chen, J., Bazzano, L., Qiao, D., Ju, Z., Chen, C.-S., & He, J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328300a24a · Cited by 129
Self-citationCalcium antagonists for acute ischemic stroke
Zhang, J., Yang, J., Zhang, C., Jiang, X., Zhou, H., & Liu, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001928.pub2 · Cited by 73
Self-citationWeaver, C. S., Leonardi-Bee, J., Bath-Hextall, F. J., & Bath, P. M. W. (2004) · Stroke · doi:10.1161/01.str.0000125010.70652.93 · Cited by 67
Calcium antagonists for acute ischemic stroke
Zhang, J., Liu, J., Li, D., Zhang, C., & Liu, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001928.pub3 · Cited by 44
Self-citationElliott, W. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.01.085 · Cited by 31
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Self-citationPowers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2018) · Stroke · doi:10.1161/str.0000000000000158 · Cited by 5,446
Metadata
- Authors
- He, J., Zhang, Y., Xu, T., Zhao, Q., Wang, D., Chen, C.-S., Tong, W., Liu, C., Xu, T., Ju, Z., Peng, Y., Peng, H., Li, Q., Geng, D., Zhang, J., Li, D., Zhang, F., Guo, L., Sun, Y., Wang, X., Cui, Y., Li, Y., Ma, D., Yang, G., Gao, Y., Yuan, X., Bazzano, L. A., & Chen, J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-02-05
- Volume
- 311
- Issue
- 5
- Pages
- 479
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2144710774
- Cited by
- 452
- References
- 31
- FWCI
- 30.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.